Dr Elaine Siegfried Discusses Skin Color, Socioeconomic Implications of Atopic Dermatitis Management

May 19th 2022, 3:45pm


Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, explains the impact of socioeconomic status on the management of atopic dermatitis in the clinical setting.

Extreme Heat Waves Linked With Higher US Mortality, Particularly Among Elderly, Black Individuals

May 19th 2022, 3:00pm


New data show extreme heat waves were associated with higher all-cause mortality throughout the United States, with increased risks seen among men, the elderly, and non-Hispanic Black individuals.

Tildrakizumab Shows Clinical Improvement of Difficult-to-Treat Areas in Psoriasis

May 18th 2022, 7:35pm


Real-world patients with psoriasis demonstrated significant improvement in difficult-to-treat scalp, nail, palmoplantar, and genital disease manifestations with the IL-23 inhibitor tildrakizumab.

Importance of Microbiome, Disease Prevention Among Topics to Be Discussed at DDW 2022

May 18th 2022, 2:30pm


Digestive Disease Week (DDW) 2022, held virtually and in San Diego, California, from May 21 to 24, will feature research and presentations exploring new ways to prevent and treat digestive diseases.

Study: In Severe Asthma, Benefits of At-Home Biologics Outweigh Disadvantages

May 17th 2022, 6:21pm


A survey of patients and health care providers found both groups favor at-home administration of biologics when possible.

Protein Biomarkers May Indicate Early Kidney Impairment, Study Finds

May 17th 2022, 4:29pm


A cross-sectional analysis found that protein biomarkers were associated with estimated glomerular filtration rate, which may capture early kidney impairment.

Diet Created to Lower Diabetes Risk Linked With Reduced Lung Cancer Incidence

May 17th 2022, 3:36pm


The findings are based off an analysis of 98,159 individuals.

Greater Biologic Persistence, Adherence Achieved With Ixekizumab for Psoriasis

May 16th 2022, 7:45pm


Significantly greater persistence, adherence, and time on monotherapy was achieved with the use of ixekizumab vs the biologics adalimumab, etanercept, secukinumab, and ustekinumab, in the treatment of moderate to severe psoriasis.

Superior Clinical Outcomes Seen in HFrEF With Early Initiation of Sacubitril/Valsartan

May 16th 2022, 10:25am


Two periods of sacubitril/valsartan initiation were compared in a study population of patients with heart failure with reduced ejection fraction (HFrEF): less than 3 months or 3 or more months following first HFrEF diagnosis.

Superior T1D Control Seen With HCL Systems vs SAP Therapy in Older Adults

May 15th 2022, 8:13pm


Type 1 diabetes (T1D) can be especially difficult to manage in older adults, so this new multinational review compared the safety and effectiveness of a hybrid closed-loop (HCL) system and sensor-augmented pump (SAP) therapy.